NAPROXENE Esoméprazole Sandoz 500mg/20mg 60 pce

7680691840029 CH-69184 M01AE52 07.10.2.
NAPROXENE Esoméprazole Sandoz 500mg/20mg 60 pce
NAPROXENE Esoméprazole Sandoz 500mg/20mg 60 pce
NAPROXENE Esoméprazole Sandoz 500mg/20mg 60 pce
1 / 3
google

Details

Product number
6918401
CPT
-
Packaging group
60
Unit
Tablette(n)
Composition
naproxenum 500 mg, esomeprazolum 20 mg ut esomeprazolum magnesicum trihydricum 22.3 mg, silica colloidalis anhydrica, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, polysorbatum 80, glyceroli monostearas 40-55, triethylis citras, lactosum monohydricum 24.055 mg, carmellosum natricum conexum, natrii stearylis fumaras, cellulosum microcristallinum, magnesii oxidum leve, povidonum K 30, calcii stearas, Überzug: hypromellosum, macrogolum 400, E 171, E 172 (flavum), pro compresso obducto corresp. natrium 1.71 mg.

Articles (1)

Naproxen Esomeprazol Sandoz 500 mg / 20 mg, Filmtabletten
Filmtabletten
60
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
01/10/2025
Patient information leaflet
Français
01/10/2025
Patient information leaflet
Italien
01/10/2025
Professional SmPC
Allemand
01/10/2025
Professional SmPC
Français
01/10/2025
Professional SmPC
Italien
01/10/2025

Detailed composition

Substance Quantity Type Category
(N/A)
500.0 MG Substance Wirkstoff (Principe actif)
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
22.3 MG Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
24.055 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
1.71 MG Substance HBESI

Reimbursement information

Public price
CHF 35.10
Specialties list
Yes
Generic
Yes
SL addition date: 01/10/2025

Authorization holder

Sandoz Pharmaceuticals AG

6343 Risch

Authorization information

Swissmedic authorization number
69184
Drug name
Naproxen Esomeprazol Sandoz, Filmtabletten
Galenic form
FILM
ATC Code
M01AE52
Authorization status
Z
Dispensation category
B
First authorization
19/11/2024
Authorization expiration date
18/11/2029
IT number
07.10.2.
Domain
Human medicine
Field of application
Antirheumatikum kombiniert mit Protonenpumpenblocker

Packaging details

Description (FR)
NAPROXENE Esoméprazole Sandoz 500mg/20mg 60 pce
Description (DE)
NAPROXEN Esomeprazol Sandoz 500mg/20mg 60 Stk
Market launch
01/09/2025
Narcotic (BTM)
No

Original drug

Vimovo, Filmtabletten
CHF 39.55
View original

Other packaging sizes

NAPROXENE Esoméprazole Sandoz 500mg/20mg 30 pce
30 TABL
View